14.06.2015 • News

Blast rocks Dynamic Plant at Nanjing

pavalena - Fotolia
pavalena - Fotolia

An explosion and fire rocked China’s Nanjing chemical industry park in Jiangsu Province on the evening of Jun. 12.

In the English translation of the report by the official Chinese news agency Xinhua said an “epoxyethane device” at a plant owned by Dynamic in the park touched off the blast and the subsequent fire that raged for nearly six hours and spread to three of six nearby 1,000 cbm chemical tanks.

Three plant workers and a firefighter were slightly injured as they were putting out the fire in Xinhua said, adding that workers were moved to “safe areas.”

The agency quotes environmental authorities as saying the incident had “little impact on the air and surrounding waterways.”

An explosion and fire rocked China’s Nanjing chemical industry park in Jiangsu Province on the evening of Jun. 12.

In the English translation of the report by the official Chinese news agency Xinhua said an “epoxyethane device” at a plant owned by Dynamic in the park touched off the blast and the subsequent fire that raged for nearly six hours and spread to three of six nearby 1,000 cbm chemical tanks.

Three plant workers and a firefighter were slightly injured as they were putting out the fire in Xinhua said, adding that workers were moved to “safe areas.”

The agency quotes environmental authorities as saying the incident had “little impact on the air and surrounding waterways.”

Many Western chemical groups have production facilities at Nanjing.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read